Organization Profile

You just read:

Oncolytics Biotech® Inc. Announces Receipt of Orphan Drug Designation from the U.S. FDA for Ovarian Cancer

News provided by

Oncolytics Biotech Inc.

Feb 11, 2015, 06:30 ET